Literature DB >> 17599607

Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene.

J Peter van Tintelen1, Rene A Tio, Wilhelmina S Kerstjens-Frederikse, Jop H van Berlo, Ludolf G Boven, Albert J H Suurmeijer, Stefan J White, Johan T den Dunnen, Gerard J te Meerman, Yvonne J Vos, Annemarie H van der Hout, Jan Osinga, Maarten P van den Berg, Dirk J van Veldhuisen, Charles H C M Buys, Robert M W Hofstra, Yigal M Pinto.   

Abstract

OBJECTIVES: The goal of this study was to identify the underlying gene defect in a family with inherited myocardial fibrosis.
BACKGROUND: A large family with an autosomal dominantly inherited form of myocardial fibrosis with a highly malignant clinical outcome has been investigated. Because myocardial fibrosis preceded the clinical and echocardiographic signs, we consider the disease to be a hereditary form of cardiac fibrosis.
METHODS: Twenty-five family members were clinically evaluated, and 5 unaffected and 8 affected family members were included in a genome-wide linkage study.
RESULTS: The highest logarithm of the odds (LOD) score (LOD = 2.6) was found in the region of the lamin AC (LMNA) gene. The LMNA mutation analysis, both by denaturing gradient gel electrophoresis and sequencing, failed to show a mutation. Subsequent Southern blotting, complementary deoxyribonucleic acid sequencing, and multiplex ligation-dependent probe amplification analysis, however, revealed a deletion of the start codon-containing exon and an adjacent noncoding exon. In vitro studies demonstrated that the deletion results in the formation of nuclear aggregates of lamin, suggesting that the mutant allele is being transcribed.
CONCLUSIONS: This novel LMNA deletion causes a distinct, highly malignant cardiomyopathy with early-onset primary cardiac fibrosis likely due to an effect of the shortened mutant protein, which secondarily leads to arrhythmias and end-stage cardiac failure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599607     DOI: 10.1016/j.jacc.2007.02.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

Review 1.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

Review 2.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

3.  Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.

Authors:  Wei Wu; Mahendra D Chordia; Barry P Hart; E Sathyajith Kumarasinghe; Min K Ji; Ajay Bhargava; Michael W Lawlor; Ji-Yeon Shin; Fusako Sera; Shunichi Homma; Antoine Muchir; Uday R Khire; Howard J Worman
Journal:  Bioorg Med Chem       Date:  2016-12-09       Impact factor: 3.641

4.  Clinical utility gene card for: dilated cardiomyopathy (CMD).

Authors:  Anna Posafalvi; Johanna C Herkert; Richard J Sinke; Maarten P van den Berg; Jens Mogensen; Jan D H Jongbloed; J Peter van Tintelen
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

5.  Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene.

Authors:  Wei Wu; Antoine Muchir; Jian Shan; Gisèle Bonne; Howard J Worman
Journal:  Circulation       Date:  2010-12-20       Impact factor: 29.690

6.  Novel Mutation in Bernard-Soulier Syndrome.

Authors:  Kirstin Sandrock; Ralf Knöfler; Andreas Greinacher; Birgitt Fürll; Sebastian Gerisch; Ulrich Schuler; Siegmund Gehrisch; Anja Busse; Barbara Zieger
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

7.  Lamin A/C dysregulation contributes to cardiac pathology in a mouse model of severe spinal muscular atrophy.

Authors:  Darija Šoltić; Hannah K Shorrock; Hazel Allardyce; Emma L Wilson; Ian Holt; Silvia A Synowsky; Sally L Shirran; Simon H Parson; Thomas H Gillingwater; Heidi R Fuller
Journal:  Hum Mol Genet       Date:  2019-11-01       Impact factor: 6.150

Review 8.  Genetic evaluation of familial cardiomyopathy.

Authors:  Daniel P Judge; Nicole M Johnson
Journal:  J Cardiovasc Transl Res       Date:  2008-04-22       Impact factor: 4.132

9.  ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene.

Authors:  Maria Chatzifrangkeskou; Caroline Le Dour; Wei Wu; John P Morrow; Leroy C Joseph; Maud Beuvin; Fusako Sera; Shunichi Homma; Nicolas Vignier; Nathalie Mougenot; Gisèle Bonne; Kenneth E Lipson; Howard J Worman; Antoine Muchir
Journal:  Hum Mol Genet       Date:  2016-04-30       Impact factor: 6.150

Review 10.  Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations.

Authors:  Howard J Worman
Journal:  Biochem Soc Trans       Date:  2017-12-01       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.